Three of the TWAS candidate susceptibility genes (EIF2AK4, SKAP1, and SNX11) have been recently identified as potential regulatory targets of endometrial cancer GWAS risk variation through enhancer-promoter chromatin looping studies23. Here, SNX11 is linked to endometrial cancer.